1800 202 8726
Pathology costs

IHC Marker Test Cost: — Why the Bill Can Exceed the Biopsy

Each IHC marker your pathologist orders is a separate test and a separate charge. A panel of 12 or more markers is routine for some cancers, and the total often exceeds the cost of the biopsy procedure itself. Most families discover this only when the bill arrives.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Billed per marker — Each stain your pathologist runs on the biopsy tissue is charged individually, whether the result is positive or negative.
  • The pathologist sets the panel — Markers are ordered on clinical grounds. The number your pathologist requests reflects what the diagnosis actually requires.
  • You can ask what is essential — Asking which markers are necessary versus confirmatory rarely delays the report and is a reasonable question before the panel is run.
  • Insurance may treat it separately — Some schemes and insurers cover the biopsy procedure but classify IHC testing under a different, lower-covered diagnostic benefit.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an indicative cost estimate

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Each IHC marker at a private laboratory in India is billed individually, typically in the range of ₹800 to ₹2,500 per marker (indicative, private labs, 2025). A panel of 12 or more markers is routine for lymphomas and some complex solid tumours. That panel's total frequently exceeds the cost of the biopsy procedure that collected the tissue.

What does IHC testing cost in India?

What you are paying forIndicative range — private lab, 2025When this applies
Single IHC marker₹800 – ₹2,500Confirming one specific finding on known tissue
4-marker panel — e.g. ER, PR, HER2, Ki-67₹3,500 – ₹8,000Standard initial workup after most breast biopsies
6- to 8-marker panel₹6,000 – ₹15,000Common for lung, gastric, and colorectal tumours
12+ marker panel₹12,000 – ₹30,000Lymphoma, unknown primary, or complex haematology — often exceeds the biopsy cost
Core needle biopsy — for comparison₹4,000 – ₹15,000Procedure only, before any staining or IHC

Why does an IHC panel sometimes cost more than the biopsy?

The biopsy collects the tissue. IHC testing is what the pathologist does to identify exactly which type of cells are in that tissue — and each answer requires a separate chemical stain, a separate slide, and a separate review under the microscope.

For breast cancer, a four-marker panel is usually sufficient. For lymphomas, tumours of unknown origin, or tissue that looks ambiguous under routine staining, your pathologist may need 12 or more markers before reaching a confident diagnosis. Each one is billed separately.

The total accumulates quickly and is rarely itemised in the paperwork you sign before the procedure. You may see a single line on the final bill — 'IHC testing' — against an amount that takes you by surprise.

What will this actually cost you?

Costs depend on the regimen, the number of cycles and your scheme eligibility. Send your reports and we will give you an itemised, indicative estimate.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Know the cost before you commit

An itemised estimate, plus a check of which schemes you may qualify for.

Book Free Consultation Call 1800 202 8726

Can you limit which IHC markers are tested?

  • Ask for a list of planned markers and an approximate total cost before the panel is sent to the laboratory.
  • Ask which markers are essential for reaching the diagnosis and which are confirmatory or optional.
  • Ask whether a phased approach is possible — running a smaller initial set and adding markers only if results are inconclusive.
  • Check with your insurer whether IHC is covered under the same benefit as the biopsy or under a separate, lower-covered diagnostic category.
  • If you are in a government scheme, ask the hospital's scheme desk whether IHC is pre-authorised alongside the biopsy procedure code — before the test is run, not after.
  • Request that the final report lists each marker tested and its individual result, so you have a complete record for second opinions.

Did you know?

The World Health Organization's classification of blood tumours identifies IHC as diagnostically essential — not optional — for most lymphoma subtypes. A panel that looks large is often the minimum your pathologist needs to give a reliable diagnosis.

Every marker on that panel is billed separately, which is why the IHC bill for a lymphoma workup can comfortably exceed the biopsy that collected the tissue.

Source: WHO Classification of Haematolymphoid Tumours, 5th edition, 2022

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is IHC testing covered by health insurance in India?

Coverage depends on your insurer and your specific policy. Many policies cover IHC as part of a hospitalisation or daycare benefit when the biopsy is also covered, but some categorise it as an outpatient diagnostic test with a lower sublimit or no cover at all. The critical step is to confirm coverage before the test is run, not after — retrospective claims for IHC are commonly disputed. Ask the hospital's insurance desk to confirm pre-authorisation in writing, and verify whether the IHC cost is included in the same authorisation as the biopsy or handled separately.

Can I ask the pathologist to reduce the number of markers?

Yes, and it is a reasonable question. A pathologist who has planned a large panel can usually explain which markers will directly affect the diagnosis or treatment plan and which are being run out of caution. Sometimes a smaller initial set is sufficient, with additional markers added only if the first results are inconclusive. This phased approach does not always save money, because a second submission to the laboratory may carry its own charges, but it means you are not paying for markers that turn out to be unnecessary. Ask your oncologist to raise this with the pathologist before the panel is finalised.

Why do different hospitals charge different amounts for the same IHC marker?

Each laboratory sets its own pricing. The charge reflects the cost of the specific antibody used, the laboratory's accreditation and quality-control overheads, and the time required for a pathologist to review and report each slide. NABL-accredited private laboratories in metro cities typically charge more than smaller laboratories in tier-2 cities for the same marker. For high-stakes markers such as HER2 or PD-L1, the method used and the quality of interpretation matter as much as the cost — a cheaper result from a less-reliable laboratory can lead to the wrong treatment decision.

Does PMJAY or Ayushman Bharat cover IHC testing?

PMJAY covers defined treatment packages, and IHC testing is included within some oncology packages rather than billed as a standalone item. Whether it applies in your case depends on the package code your treatment falls under and whether the empanelled hospital has included IHC within that package. Ask the hospital's Ayushman Bharat desk before the biopsy takes place. Scheme package lists are updated periodically, so the hospital's desk holds the current applicable version. Coverage cannot be guaranteed in advance by any treating centre.

How do I know if I was charged for markers I did not need?

Once the report is ready, check that each marker listed has a result and a note on its clinical relevance in the pathologist's narrative. A marker described as 'not contributory' may have been ordered when the diagnosis was still unclear — this is not necessarily wrong, because pathologists sometimes run a broad panel upfront when the tissue picture is ambiguous. It is worth discussing with your oncologist whether all markers were necessary in your specific case. For complex diagnoses, a second opinion on the pathology from an accredited centre is always reasonable, and your original slides can be sent for review.

Is IHC the same as molecular or genetic testing, and does the cost difference matter?

They are different tests at very different price points. IHC detects specific proteins in tissue using chemical stains and is relatively affordable. Molecular tests — such as next-generation sequencing, FISH for gene amplification, or PCR-based assays — examine the DNA or RNA of the tumour and cost considerably more, sometimes several times the cost of a full IHC panel. Some markers, such as HER2, can be assessed by either IHC or FISH, and your oncologist will tell you which method is required for your situation. Knowing which type of test is being ordered helps you prepare for the right cost range before you commit.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation